Form 4 holding
Director
Aurinia Pharmaceuticals Inc.
- Security class
- Common Stock
- Shares / value
- 28,141
- Estimated value
- $161,529
- Report date
- 21 May 2024
- Price
- $5.74
- Ownership
- Direct
Ph.D. Daniel Billen - Director at Aurinia Pharmaceuticals Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- AUPH on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Ph.D. Daniel Billen since 04 Aug 2025
Reported holdings for Ph.D. Daniel Billen in Aurinia Pharmaceuticals Inc.
Form 4 holding
Director
Aurinia Pharmaceuticals Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 15,234
- Estimated value
- Report date
- 19 May 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Aurinia Pharmaceuticals Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- Report date
- 18 May 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Ph.D. Daniel Billen in Aurinia Pharmaceuticals Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.